SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation

Overview of attention for article published in Frontiers in immunology, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 6 X users

patent: 3 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING T CELL-RELATED DISORDERS

Application WO-2023095802-A1

World Intellectual Property Organisation (WIPO)

MONOCLONAL ANTIBODY TARGETING SIRPα AND USE THEREOF

Application WO-2023020459-A1

World Intellectual Property Organisation (WIPO)

THERAPEUTIC SIRPalpha ANTIBODIES

Application EP-3880239-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.